Pharmasource (UK) Ltd - Limited company - abbreviated - 11.6

Pharmasource (UK) Ltd - Limited company - abbreviated - 11.6


04295286 1.10.13 30.9.14 30.9.14 Company accounts Private Limited Company FY true false true false true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure042952862013-09-30042952862014-09-30042952862013-10-012014-09-30042952862012-09-30042952862012-10-012013-09-30042952862013-09-3004295286ns12:England2013-10-012014-09-3004295286ns14:PoundSterling2013-10-012014-09-3004295286ns7:Director12013-10-012014-09-3004295286ns7:OrdinaryShareClass12013-10-012014-09-3004295286ns7:Director22013-10-012014-09-3004295286ns7:RegisteredOffice2013-10-012014-09-3004295286ns7:EntityAccountantsOrAuditors2013-10-012014-09-3004295286ns5:PlantMachinery2013-10-012014-09-3004295286ns7:OrdinaryShareClass12014-09-3004295286ns7:OrdinaryShareClass12013-09-30
REGISTERED NUMBER: 04295286 (England and Wales)















ABBREVIATED UNAUDITED ACCOUNTS FOR THE YEAR ENDED 30 SEPTEMBER 2014

FOR

PHARMASOURCE (UK) LTD

PHARMASOURCE (UK) LTD (REGISTERED NUMBER: 04295286)






CONTENTS OF THE ABBREVIATED ACCOUNTS
for the Year Ended 30 September 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

PHARMASOURCE (UK) LTD

COMPANY INFORMATION
for the Year Ended 30 September 2014







DIRECTOR: Mr A P Janmohamed





REGISTERED OFFICE: 6b Parkway
Porters Wood
St Albans
Hertfordshire
AL3 6PA





REGISTERED NUMBER: 04295286 (England and Wales)





ACCOUNTANTS: Hanburys Limited
Chartered Certified Accountants
6b Parkway
Porters Wood
St Albans
Hertfordshire
AL3 6PA

PHARMASOURCE (UK) LTD (REGISTERED NUMBER: 04295286)

ABBREVIATED BALANCE SHEET
30 September 2014

30.9.14 30.9.13
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 112 149

CURRENT ASSETS
Debtors 113,340 62,048

CREDITORS
Amounts falling due within one year 248,192 223,191
NET CURRENT LIABILITIES (134,852 ) (161,143 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(134,740
)
(160,994
)

CAPITAL AND RESERVES
Called up share capital 3 2 2
Profit and loss account (134,742 ) (160,996 )
SHAREHOLDERS' FUNDS (134,740 ) (160,994 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2014 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 30 June 2015 and were signed by:





Mr A P Janmohamed - Director


PHARMASOURCE (UK) LTD (REGISTERED NUMBER: 04295286)

NOTES TO THE ABBREVIATED ACCOUNTS
for the Year Ended 30 September 2014

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The accounts have been prepared on a going concern basis which assumes that the company will continue to
trade. The validity of this assumption is dependent on sufficient and continuing financial support being made
available by the company's director and the creditors. If the company were unable to continue to trade
adjustments would have to be made to reduce the value of assets to their realisable amount, to reclassify fixed
assets as current assets and to provide for any further liabilities that may arise.

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery - 25% on reducing balance

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 October 2013
and 30 September 2014 2,279
DEPRECIATION
At 1 October 2013 2,130
Charge for year 37
At 30 September 2014 2,167
NET BOOK VALUE
At 30 September 2014 112
At 30 September 2013 149

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.14 30.9.13
value: £    £   
2 Ordinary £1 2 2